Spanish version of the Screen for Cognitive Impairment in Psychiatry (SCIP-S): Psychometric properties of a brief scale for cognitive evaluation in schizophrenia

Schizophrenia Research

Volumn 99, Issue 1-3, 2008, Pages 139-148

  Pino, Oscar ^a   Guilera, Georgina ^b   Rojo, J Emilio ^a   Gómez Benito, Juana ^b   Bernardo, Miguel ^c   Crespo Facorro, Benedicto ^d   Cuesta, Manuel J ^e   Franco, Manuel ^f   Martinez Aran, Anabel ^c   Segarra, Nuria ^c   Tabarés Seisdedos, Rafael ^g   Vieta, Eduard ^c   Purdon, Scot E ^h   Díez, Teresa ⁱ   Rejas, Javier ⁱ  

^a Benito Menni Complex Assistencial en Salut Mental   (Spain)

^b UNIVERSITY OF BARCELONA   (Spain)

^c HOSPITAL CLÍNIC   (Spain)

^d HOSPITAL UNIVERSITARIO MARQUÉS DE VALDECILLA   (Spain)

^e Universidad Pública de Navarra   (Spain)

^f Hospital Provincial de Zamora   (Spain)

^g UNIVERSITY OF VALENCIA   (Spain)

^h UNIVERSITY OF ALBERTA   (Canada)

ⁱ PFIZER INC   (United States)

Author keywords

Cognitive functions; Schizophrenia; SCIP; Screening

Indexed keywords

ADULT; APTITUDE TEST; ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROLOGIC EXAMINATION; OUTPATIENT CARE; PATIENT ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; SCHIZOPHRENIA; SCORING SYSTEM; SCREENING; SPAIN; STATISTICAL ANALYSIS;

ADOLESCENT; ADULT; COGNITION DISORDERS; CROSS-CULTURAL COMPARISON; FEMALE; HUMANS; LANGUAGE; MALE; MASS SCREENING; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PSYCHOMETRICS; PSYCHOTIC DISORDERS; REFERENCE VALUES; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SPAIN;

EID: 39149120566     PISSN: 09209964     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.schres.2007.09.012     Document Type: Article

References (45)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders. Text Revision (DSM-IV TR). Fourth Edition (2000) Washington DC.
2. Andreasen N.C., Flaum M., and Arndt S. The Comprehensive Assessment of Symptoms and History (CASH). An instrument for assending diagnosis and psychopathology. Arch. Gen. Psychiatr. 49 (1992) 615-623
3. Army Individual Test Battery. Manual of Directions and Scoring (1944), War Department, Adjutant General's Office, Washington, DC
4. Berg E.A. Sample objective test for measuring flexibility and thinking. J. Gen. Psych. 39 (1948) 15-22
5. Colom F., Vieta E., Martinez-Aran A., Garcia-Garcia M., Reinares M., Torrent C., Goikolea J.M., Banus S., and Salamero M. Spanish version of a scale for the assessment of mania: validity and reliability of the Young Mania Rating Scale. Med. Clin. (Barc) 119 (2002) 366-371
6. Cuesta M.J., Peralta V., and Zarzuela A. Illness duration and neuropsychological impairments in schizophrenia. Schizophr. Res. 33 3 (1998) 141-150
7. Cuesta M.J., and Peralta V. Cognitive disorders in the positive, negative and disorganization syndromes of schizophrenia. Psychiatry Res. 58 3 (1995) 227-235
8. Cuesta M.J., Peralta V., and Zarzuela A. Effects of olanzapine and other antipsychotics on cognitive function in chronic schizophrenia: a longitudinal study. Schizophr. Res. 48 1 (2001) 17-28
9. Daban C., Martinez-Aran A., Torrent C., Tabares-Seisdedos R., Balanza-Martinez V., Salazar-Fraile J., Selva-Vera G., and Vieta E. Specificity of cognitive deficits in bipolar disorder versus schizophrenia. A systematic review. Psychother. Psychosom. 75 (2006) 72-84
10. Estes W.K. Learning theory and intelligence. Am. Psychol. 29 (1974) 740-749
11. Faustman W.O., Moses Jr. J.A., and Csernansky J.G. Limitations of the mini-mental state: a practical method for grading the cognitive state of patients for the clinician. Acta Psychiatr. Scand. 81 (1990) 126-131
12. Folstein M.F., Folstein S.E., and McHugh P.R. Mini-mental state: a practical method for grading the cognitive state of patients for the clinician. J Psychiat Res. 12 3 (1975) 189-198
13. Gold J.M., Queern C., Iannone V.N., and Buchanan R.W. Repeatable Battery for the Assessment of Neuropsychological Status as a screening test in schizophrenia, I: sensitivity, reliability, and validity. Am. J. Psychiatry 156 (1999) 1944-1950
14. Goldman H.H., Skodol A.E., and Lave T.R. Revising axis V for DSM-IV: a review of measures of social functioning. Am. J. Psychiatry 149 (1992) 1148-1156
15. Green M.F. What are the functional consequences of neurocognitive deficits in schizophrenia? Am. J. Psychiatry 153 (1996) 321-330
16. Green M.F., Kern R.S., and Heaton P.K. Longitudinal studies of cognition and functional outcome in schizophrenia: implications for MATRICS. Schizophr. Res. 72 1 (2004) 41-51
17. Green M.F., and Nuechterlein K.H. The MATRICS initiative: developing a consensus cognitive battery for clinical trials. Schizophr. Res. 72 1 (2004) 1-3
18. Green M.F., Olivier B., Crawley J.N., Penn D.L., and Silverstein S. Social cognition in schizophrenia: recommendations from the measurement and treatment research to improve cognition in schizophrenia new approaches conference. Schizophr. Bull. 31 4 (2005) 882-887
19. Guy W. Clinical Global Impressions. ECDEU Assessment Manual for Psychopharmacology, revised (1976), National Institute of Mental Health, Rockville 217-222
20. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 23 (1960) 56-62
21. Heaton R.K., Chelune G.J., Talley J.L., Kay G.G., and Curtiss G. Wisconsin Card Sorting Test (WCST) Manual-Revised and Expanded (1993), Psychological Assessment Resources, Odessa, FL
22. Heinrichs R.W., and Zakzanis K.K. Neurocognitive deficit in schizophrenia: a quantitative review of the evidence. Neuropsychology 12 (1998) 426-445
23. Kay S.R., Opler L.A., and Fiszbein A. The Positive and Negative Syndrome Scale (PANSS). Rat. Man. Soc. Behav. Sci. Doc. vol 17 (1986) 28-29
24. Keefe R.S.E., Goldberg T.E., Harvey P.D., Gold J.M., Poe M.P., and Coughenour L. The Brief Assessment of Cognition in Schizophrenia: reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophr. Res. 68 (2004) 283-297
25. Kern R.S., Green M.F., Nuechterlein K.H., and Deng B.H. NIMH-MATRICS survey on assessment of neurocognition in schizophrenia. Schizophr. Res. 72 1 (2004) 11-19
26. Kiernan R.J., Mueller J., Langston J.W., and Van Dyke C. The Neurobehavioral Cognitive Status Examination: a brief but quantitative approach to cognitive assessment. Ann Intern. Med. 107 4 (1987) 481-485
27. Manning V., Wanigaratne S., Best D., Strathdee G., Schrover I., and Gossop M. Screening for cognitive functioning in psychiatric outpatients with schizophrenia, alcohol dependence, and dual diagnosis. Schizophr. Res. 91 (2007) 151-158
28. Martínez-Arán A., Penadés R., Vieta E., Colom F., Reinares M., Benabarre A., Salamero M., and Gastó C. Executive function in remitted bipolar and schizophrenic patients and its relationship with functional outcome. Psychother. Psychosom. 71 (2002) 39-46
29. Meltzer H.Y., Thompson P.A., Lee M.A., and Ranjan R. Neuropsychologic deficits in schizophrenia, relation to social function and effect of antipsychotic drug treatment. Neuropsychopharmacology 14 (1996) 27S-33S
30. Nuechterlein K.H., Barch D.M., Gold J.M., Goldberg T.E., Green M.F., and Heaton R.K. Identification of separable cognitive factors in schizophrenia. Schizophr. Res. 72 1 (2004) 29-39
31. Oldfield R.C. The assessment and analysis of handedness: The Edinburgh Inventory Test. Neuropsychologia 9 (1971) 97-113
32. Penadés R., Gastó C., Boget T., Catalán R., and Salamero M. Deficit in schizophrenia: the relationship between negative symptoms and neurocognition. Compr. Psychiat. 42 (2001) 64-69
33. Peralta V., and Cuesta M.J. Escala del síndrome positivo y negativo en la esquizofrenia (PANSS), Manual de puntuación (2004)
34. Pino O., Guilera G., Gómez J., Rojo E., Vallejo J., and Purdon S.E. Escala breve para evaluar la afectación cognitiva en pacientes psiquiátricos. Psicothema 18 3 (2006) 447-452
35. Purdon S.E. The Screen for Cognitive Impairment in Psychiatry (SCIP): Instructions and three alternate forms (2005), PNL Inc, Edmonton, Alberta
36. Randolph C., Tierney M.C., Mohr E., and Chase T.N. The Repeatable Battery for the Assessment of Neuropsychological Status (RBANS): preliminary clinical validity. J. Clin. Exp. Neuropsychol. 20 3 (1998) 310-319
37. Robinson B.F., and Bakeman R. ComKappa: a Windows 95 program for calculating kappa and related statistics. Behav. Res. Meth. Instrum. Comput. 30 (1998) 731-732
38. Rosen W.G. Verbal fluency in aging and dementia. J. Clin. Neuropsychol. 2 (1980) 135-146
39. Sanchez-Moreno J., Villagran J.M., Gutiérrez J.R., Camacho M., Ocio S., Palao D., Querejeta I., Gascón J., Sanchez G., Vieta E., for the EDHIPO (hypomania detection study) group, in press. Adaptation and validation of the Spanish version of the mood disorder questionnaire (MDQ) for the detection of bipolar disorder. Bipolar. Disord.
40. Vieta E., Sanchez-Moreno J., Bulbena A., Chamorro L., Ramos J.L., Artal J., Perez F., Oliveras M.A., Valle J., Lahuerta J., Angst J., and for the EDHIPO (hypomania detection study) group. Cross validation with the mood disorder questionnaire (MDQ) of an instrument for the detection of hypomania in Spanish: the 32 item hypomania symptom check list (HCL-32). J. Affect. Disord. 101 (2007) 43-55
41. Wechsler D. Wechsler Adults Intelligence Scale 3, WAIS-III manual. Spanish version (1999), TEA Ediciones, Madrid
42. Wechsler D. Wechsler Memory Scale 3, WMS-III manual. Spanish version (2004), TEA Ediciones, Madrid
43. Woodcock R.W., McGrew K.S., and Mather N. Woodcock-Johnson III tests of cognitive abilities (2001), Itasca, IL, Riverside
44. Woodward N., Purdon S.E., Meltzer H.Y., and Zald D.H. A meta-analysis of neuropsychological change to clozapine, olanzapine, quetiapine and risperidone in schizophrenia. Int. J. Neuropsychopharmacol. 8 (2005) 1-16
45. Woodward N.D., Purdon S.E., Meltzer H.Y., and Zald D.H. A meta-analysis of cognitive change with haloperidol in clinical trials of atypical antipsychotics: dose effects and comparison to practice effects. Schizoph. Res. 89 (2007) 211-224